Skip to main navigation Skip to search Skip to main content

Development of a methodology for the evaluation of tumor necrosis factor antibody (anti-TNF-alpha) in patients with treatment of biological products through the use of nanobiosensors

Research output: Contribution to specialist publicationArticle

Cite this